These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 28612554)
1. [The Preliminary Investigation of GLP-1 Receptor Agonist on Liver Steatosis in Obese Mice]. Wang X; He H; Liang LB; Zhang M; Li SY; Li SQ; An ZM; Huang HJ Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 48(1):28-32. PubMed ID: 28612554 [TBL] [Abstract][Full Text] [Related]
2. Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease. Li S; Wang X; Zhang J; Li J; Liu X; Ma Y; Han C; Zhang L; Zheng L Braz J Med Biol Res; 2018; 51(8):e7299. PubMed ID: 29924135 [TBL] [Abstract][Full Text] [Related]
3. Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor. Tatarkiewicz K; Sablan EJ; Polizzi CJ; Villescaz C; Parkes DG Am J Physiol Regul Integr Comp Physiol; 2014 Apr; 306(7):R490-8. PubMed ID: 24477544 [TBL] [Abstract][Full Text] [Related]
4. Exendin-4 improves steatohepatitis by increasing Sirt1 expression in high-fat diet-induced obese C57BL/6J mice. Lee J; Hong SW; Chae SW; Kim DH; Choi JH; Bae JC; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Kim SW; Lee WY PLoS One; 2012; 7(2):e31394. PubMed ID: 22363635 [TBL] [Abstract][Full Text] [Related]
5. Time course of cardiometabolic alterations in a high fat high sucrose diet mice model and improvement after GLP-1 analog treatment using multimodal cardiovascular magnetic resonance. Abdesselam I; Pepino P; Troalen T; Macia M; Ancel P; Masi B; Fourny N; Gaborit B; Giannesini B; Kober F; Dutour A; Bernard M J Cardiovasc Magn Reson; 2015 Nov; 17():95. PubMed ID: 26546347 [TBL] [Abstract][Full Text] [Related]
6. Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide to Characterize Its Antiobesity Effects in Diet-Induced Obese Mice. Iwasaki S; Hamada T; Chisaki I; Andou T; Sano N; Furuta A; Amano N J Pharmacol Exp Ther; 2017 Sep; 362(3):441-449. PubMed ID: 28698254 [TBL] [Abstract][Full Text] [Related]
7. GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1. Xu F; Lin B; Zheng X; Chen Z; Cao H; Xu H; Liang H; Weng J Diabetologia; 2016 May; 59(5):1059-69. PubMed ID: 26924394 [TBL] [Abstract][Full Text] [Related]
8. Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats. Akaslan SB; Degertekin CK; Yilmaz G; Cakir N; Arslan M; Toruner FB Metab Syndr Relat Disord; 2013 Aug; 11(4):243-50. PubMed ID: 23544853 [TBL] [Abstract][Full Text] [Related]
9. Exenatide improves liver mitochondrial dysfunction and insulin resistance by reducing oxidative stress in high fat diet-induced obese mice. Wang Z; Hou L; Huang L; Guo J; Zhou X Biochem Biophys Res Commun; 2017 Apr; 486(1):116-123. PubMed ID: 28274877 [TBL] [Abstract][Full Text] [Related]
10. GLP-1 Receptor Agonist Exenatide Attenuates the Detrimental Effects of Obesity on Inflammatory Profile in Testis and Sperm Quality in Mice. Zhang E; Xu F; Liang H; Yan J; Xu H; Li Z; Wen X; Weng J Am J Reprod Immunol; 2015 Nov; 74(5):457-66. PubMed ID: 26287267 [TBL] [Abstract][Full Text] [Related]
11. SIRT1/HSF1/HSP pathway is essential for exenatide-alleviated, lipid-induced hepatic endoplasmic reticulum stress. Zheng X; Xu F; Liang H; Cao H; Cai M; Xu W; Weng J Hepatology; 2017 Sep; 66(3):809-824. PubMed ID: 28439947 [TBL] [Abstract][Full Text] [Related]
12. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105 [TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271 [TBL] [Abstract][Full Text] [Related]
15. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice. Ding X; Saxena NK; Lin S; Gupta NA; Anania FA Hepatology; 2006 Jan; 43(1):173-81. PubMed ID: 16374859 [TBL] [Abstract][Full Text] [Related]
16. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance. Khound R; Taher J; Baker C; Adeli K; Su Q Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588 [TBL] [Abstract][Full Text] [Related]
17. Exenatide reverses dysregulated microRNAs in high-fat diet-induced obese mice. Lee IS; Park KC; Yang KJ; Choi H; Jang YS; Lee JM; Kim HS Obes Res Clin Pract; 2016; 10(3):315-26. PubMed ID: 26314504 [TBL] [Abstract][Full Text] [Related]
18. Anti-obesogenic and hypolipidemic effects of a glucagon-like peptide-1 receptor agonist derived from the saliva of the Gila monster. Alves PL; Abdalla FMF; Alponti RF; Silveira PF Toxicon; 2017 Sep; 135():1-11. PubMed ID: 28579479 [TBL] [Abstract][Full Text] [Related]
19. Effects of exenatide therapy on insulin resistance in the skeletal muscles of high-fat diet and low-dose streptozotocin-induced diabetic rats. Wu H; Sui C; Xia F; Zhai H; Zhang H; Xu H; Weng P; Lu Y Endocr Res; 2016; 41(1):1-7. PubMed ID: 26361069 [TBL] [Abstract][Full Text] [Related]
20. [Effect of exendin-4 on lipid deposition in skeletal muscle of diet-induced obese mice and its underlying mechanism]. Cao HY; Xu F; Chen ZL; Lin BS; Zheng XB; Yuan SH; Liang H; Weng JP Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(2):131-136. PubMed ID: 28088959 [No Abstract] [Full Text] [Related] [Next] [New Search]